Tag: Eculizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eculizumab

Paroxysmal Nocturnal Hemoglobinuria Market is Expected - openPR.com

Added to Collection on: 2024-05-01 15:57:31

Tags for this article:

Immunosuppressants
Orphan drugs
Hematology
Monoclonal antibodies
Complement system
Pegcetacoplan
Alexion Pharmaceuticals
PNH
Danicopan
Paroxysmal nocturnal hemoglobinuria
Crovalimab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Ravulizumab Outperforms NMOSD Therapies in Preventing Relapse, Meta-Analysis Reveals

Added to Collection on: 2024-05-14 19:11:40

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Inebilizumab
Satralizumab
Eculizumab
Multiple sclerosis
Ravulizumab
Relapse prevention
Aquaporin-4

Click the tags to see associated articles and topics

View Article Details
Reviewing Ravulizumab's Long-Term Profile as New NMOSD Treatment - NeurologyLive

Added to Collection on: 2024-05-18 19:10:46

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Ravulizumab
Multiple sclerosis
Horizon Therapeutics
Genentech

Click the tags to see associated articles and topics

View Article Details
FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Amgen's rare-disease treatment biosimilar Bkemv gets FDA approval | Morningstar

Added to Collection on: 2024-05-29 10:54:38

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Alexion Pharmaceuticals
AstraZeneca
Nephrology
Eculizumab
Hemolysis
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hematologic disease
Paroxysmal nocturnal hemoglobinuria
Amgen
Soliris

Click the tags to see associated articles and topics

View Article Details
Two novel biosimilars approved in EU and US - European Pharmaceutical Review

Added to Collection on: 2024-05-29 16:41:40

Tags for this article:

Monoclonal antibodies
Acquired hemolytic anemia
Orphan drugs
Immunosuppressants
Eculizumab
Omalizumab
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Celltrion
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hemolysis

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Loses Bid to Block Soliris Biosimilar During Appeal - Bloomberg Law News

Added to Collection on: 2024-06-18 16:30:25

Tags for this article:

Specialty drugs
Immunosuppressants
Monoclonal antibodies
Orphan drugs
Samsung
Samsung Biologics
Eculizumab
Alexion Pharmaceuticals
AstraZeneca
Biosimilar
Biopharmaceutical
Pharmaceutical industry in India
AstraZeneca plc
Alexion Pharmaceuticals Inc.
Samsung BioLogics Co

Click the tags to see associated articles and topics

View Article Details
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults ... - Placera

Added to Collection on: 2024-07-23 17:05:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Rare diseases
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Alexion Pharmaceuticals
Danicopan
Hemolytic anemia
Hemolysis
Soliris

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Treatment Market 2034: - openPR.com

Added to Collection on: 2024-08-26 15:17:01

Tags for this article:

Blood disorders
Monoclonal antibodies
Acquired hemolytic anemia
Nephrology
Ahus
Complement system
Atypical hemolytic uremic syndrome
Alexion Pharmaceuticals
Hemolytic–uremic syndrome
Hemolysis
Complement factor I
Eculizumab

Click the tags to see associated articles and topics

View Article Details
NICE recommendation for new Alexion PNH treatment - PharmaTimes

Added to Collection on: 2024-10-24 15:34:41

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Rare diseases
Complement system
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemolysis
Hemolytic anemia
Factor D
AstraZeneca
Alexion

Click the tags to see associated articles and topics

View Article Details